Circulating galectin-3 has been suggested as a potential biomarker for diabetic nephropathy progression and cardiovascular disease prognosis linked to myocardial fibrosis, tissue remodelling, and heart failure development [53,54,55]. The gene discussed is LGALS3; the disease is diabetic kidney disease.